The Patient Impact of 10 Years of Ocrelizumab Treatment in Multiple Sclerosis: Long-Term Data from the Phase III OPERA and ORATORIO Studie

https://medically.roche.com/content/dam/pdmahub/restricted/neurology/ectrims-2023/ECTRIMS-2023-poster-weber-the-patient-impact-of-10-years-of-ocrelizumab.pdf